J J Low
Overview
Explore the profile of J J Low including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hnin Y, Ong L, Tsai C, Ong S, Yee S, Choo B, et al.
Lymphology
. 2019 May;
51(4):174-183.
PMID: 31119907
This is a randomized pilot study evaluating the effectiveness of customized compression garments (CG) in reducing the risk of lower limb lymphedema (LLL) in gynecological cancer patients. Patients who completed...
2.
Wilton S, Fetterman M, Low J, You G, Jiang Z, Xu J
Opt Express
. 2014 Jun;
22 Suppl 1:A35-43.
PMID: 24921998
In this paper, Monte Carlo simulations were performed to determine the potential efficiencies of luminescent solar concentrator (LSC) systems using PbSe quantum dots (QDs) as the active fluorescent material. The...
3.
Koh S, Razvi K, Chan Y, Narasimhan K, Ilancheran A, Low J, et al.
Arch Gynecol Obstet
. 2010 Aug;
284(1):183-90.
PMID: 20680316
Purpose: To assess known cancer biomarkers CA-125, human tissue kallikreins KLK6 and KLK10, hemostatic markers and age with 5-year survival outcome from epithelial ovarian cancer. Methods: Forty-one benign cyst cohorts...
4.
Wong L, See H, Khoo-Tan H, Low J, Ng W, Low J
Int J Gynecol Cancer
. 2006 Jun;
16(3):1364-9.
PMID: 16803531
The role of adjuvant therapy for malignant mixed müllerian tumors of the uterus has not been established. Our aim was to review our experience with sequential adjuvant therapy using cisplatin...
5.
Chee J, Ho T, Tay E, Low J, Yam K
Ann Acad Med Singap
. 2003 Nov;
32(5):670-5.
PMID: 14626800
Introduction: In 1988, FIGO added lymph node surgery to the staging system for endometrial cancer. This change remains controversial to date. From our study we aim to determine the significance...
6.
Han C, Low J, Yeo R, Lee K, Khoo-Tan H, Tay E, et al.
Ann Acad Med Singap
. 2003 Nov;
32(5):665-9.
PMID: 14626799
Introduction: The objectives of this review were to document the surgico-pathological characteristics of surgically resected FIGO stage 1B2 cervical carcinoma and to review our overall experience with this disease. Materials...
7.
Ankudinov A, Rehr J, Low J, Bare S
J Synchrotron Radiat
. 2001 Aug;
8(Pt 2):578-80.
PMID: 11512857
The sensitivity of Pt L-edge XANES to local geometric and electronic structure in various Pt(n) clusters is investigated using the ab initio self-consistent FEFF8 code. Calculations based on FEFF8 are...
8.
Low J, Perrin L, Crandon A, Hacker N
Cancer
. 2000 Aug;
89(2):391-8.
PMID: 10918171
Background: Effective combination chemotherapy has improved the previously dismal prognosis for malignant ovarian germ cell tumors (MOGCT) dramatically. In young patients, conservative surgery with adjuvant chemotherapy has made the preservation...
9.
Mize G, Ruan H, Low J, Morris D
J Biol Chem
. 1998 Nov;
273(49):32500-5.
PMID: 9829983
The upstream open reading frame (uORF) in the 5' leader of the mammalian mRNA encoding S-adenosylmethionine decarboxylase (AdoMetDC) serves as a negative regulatory element by suppressing translation of the associated...
10.
Low J, Yeo G
Singapore Med J
. 1995 Oct;
36(5):505-9.
PMID: 8882535
Objectives: This paper reviews the cases of eclampsia managed at the Kandang Kerbau Hospital with respect to incidence, management, maternal and perinatal outcome. Method: A retrospective analysis of eclampsia occurring...